BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26816614)

  • 1. The binding specificity of Translocated in LipoSarcoma/FUsed in Sarcoma with lncRNA transcribed from the promoter region of cyclin D1.
    Yoneda R; Suzuki S; Mashima T; Kondo K; Nagata T; Katahira M; Kurokawa R
    Cell Biosci; 2016; 6():4. PubMed ID: 26816614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA
    Yoneda R; Ueda N; Uranishi K; Hirasaki M; Kurokawa R
    J Biol Chem; 2020 Apr; 295(17):5626-5639. PubMed ID: 32165496
    [No Abstract]   [Full Text] [Related]  

  • 3. Arginine methylation of translocated in liposarcoma (TLS) inhibits its binding to long noncoding RNA, abrogating TLS-mediated repression of CBP/p300 activity.
    Cui W; Yoneda R; Ueda N; Kurokawa R
    J Biol Chem; 2018 Jul; 293(28):10937-10948. PubMed ID: 29784880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA sequence and length contribute to RNA-induced conformational change of TLS/FUS.
    Hamad N; Mashima T; Yamaoki Y; Kondo K; Yoneda R; Oyoshi T; Kurokawa R; Nagata T; Katahira M
    Sci Rep; 2020 Feb; 10(1):2629. PubMed ID: 32060318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS.
    Kurokawa R
    Adv Exp Med Biol; 2011; 722():196-208. PubMed ID: 21915790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter-associated noncoding RNA from the CCND1 promoter.
    Song X; Wang X; Arai S; Kurokawa R
    Methods Mol Biol; 2012; 809():609-22. PubMed ID: 22113303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Yoneda R; Ueda N; Kurokawa R
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-quadruplex binding ability of TLS/FUS depends on the β-spiral structure of the RGG domain.
    Yagi R; Miyazaki T; Oyoshi T
    Nucleic Acids Res; 2018 Jul; 46(12):5894-5901. PubMed ID: 29800261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a mouse monoclonal antibody for the detection of asymmetric dimethylarginine of Translocated in LipoSarcoma/FUsed in Sarcoma and its application in analyzing methylated TLS.
    Fujimoto K; Kurokawa R
    Cell Biosci; 2014; 4():77. PubMed ID: 25810899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein.
    Yang S; Warraich ST; Nicholson GA; Blair IP
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1408-11. PubMed ID: 20541619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain architectures and characterization of an RNA-binding protein, TLS.
    Iko Y; Kodama TS; Kasai N; Oyama T; Morita EH; Muto T; Okumura M; Fujii R; Takumi T; Tate S; Morikawa K
    J Biol Chem; 2004 Oct; 279(43):44834-40. PubMed ID: 15299008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
    Wang XN; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plastic roles of phenylalanine and tyrosine residues of TLS/FUS in complex formation with the G-quadruplexes of telomeric DNA and TERRA.
    Kondo K; Mashima T; Oyoshi T; Yagi R; Kurokawa R; Kobayashi N; Nagata T; Katahira M
    Sci Rep; 2018 Feb; 8(1):2864. PubMed ID: 29434328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements.
    Tan AY; Riley TR; Coady T; Bussemaker HJ; Manley JL
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6030-5. PubMed ID: 22460799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Promoter-Associated Noncoding RNA
    Palombo R; Frisone P; Fidaleo M; Mercatelli N; Sette C; Paronetto MP
    Cancer Res; 2019 Jul; 79(14):3570-3582. PubMed ID: 31072811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.
    Morohoshi F; Ootsuka Y; Arai K; Ichikawa H; Mitani S; Munakata N; Ohki M
    Gene; 1998 Oct; 221(2):191-8. PubMed ID: 9795213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
    Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
    J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyotrophic lateral sclerosis (ALS) with the mutations in the fused in sarcoma/translocated in liposarcoma gene].
    Aoki M
    Rinsho Shinkeigaku; 2013; 53(11):1080-3. PubMed ID: 24291885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
    Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ; Volkening K
    FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.